Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

The Florida Python Challenge is arguably the most well-known and well-attended snake hunt in the country. And according to the results released Wednesday, the 2025 Challenge that took place in July ...

A career coach's blunt take on how to answer one of the most common job interview questions has drawn millions of views—and a flurry of diverse opinions—after going viral on TikTok. Anna Papalia, a ...

You only get one chance to make a first impression, as the saying goes, and there's no situation where that's more important than job interviews. We all take great care to make sure we're dressed and ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

As of March 31, Recursion Pharmaceuticals had a cash position of $509 million. Following Tuesday’s layoffs, the biotech expects its runway to last into the fourth quarter of 2027. Recursion ...

A post about a job candidate who claimed that a human resources director asked whether they were planning to have children during a final interview for a senior developer role has gone viral on Reddit ...

These days, Jeff Bezos might spend more time planning his lavish Venetian wedding than hiring frontline engineers and executives. But back in the day when he was actively leading Amazon, Bezos always ...

The business of using artificial intelligence to find new drugs is starting to consolidate. The AI-powered drug discovery firm Recursion Pharmaceuticals will buy rival Exscientia in an all-stock deal ...